Sign In

Kaley Wilson

Board Member at Crohn's and Colitis Canada

Kaley Wilson is an accomplished professional currently working at adMare BioInnovations with an impressive background in the fields of Immunology, Biochemistry, and Cancer.

She holds a PhD from The University of British Columbia and has been actively involved in various organizations, showcasing her expertise and leadership skills in the industry.

Kaley Wilson has assumed roles such as Director of Business Development at Quark Venture and held board memberships at several esteemed organizations including Crohn's and Colitis Canada, Microbion Corporation, and Canary Medical Inc.

Her experience also includes serving as the Interim CEO at Sitka Biopharma and ARTMS Products Inc, demonstrating a diverse skill set in executive management.

Moreover, Kaley Wilson has contributed significantly to research and commercialization efforts in her past roles at organizations such as The Centre for Drug Research and Development, Nanomedicines Canada, and GlycoNet.

With a strong academic foundation and extensive experience in business development, partnerships, and project evaluation, Kaley Wilson continues to make noteworthy contributions to the biotechnology and pharmaceutical sectors.

Kaley Wilson
Add to my network

Location

Vancouver, British Columbia, Canada